May 01, 2024
A New Jersey federal judge has signed off on a consent judgment that permanently bars Chinese drugmaker Jiangsu Hengrui Pharmaceuticals Co. from misappropriating Johnson and Johnson's pharmaceutical subsidiary Janssen's trade secrets for its popular chemotherapy drug Yondelis.
November 21, 2023
A Chinese drugmaker asked a New Jersey federal judge to toss a claim from Johnson and Johnson's pharmaceutical subsidiary Janssen, which has accused it of conspiring with its own subsidiary to misappropriate trade secrets.